Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis

Summary Background Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited. Aims To assess national trends in VTE‐associated hospitalisations among patients with IBD as well a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2022-10, Vol.56 (7), p.1157-1167
Hauptverfasser: Faye, Adam S., Lee, Kate E., Dodson, John, Chodosh, Joshua, Hudesman, David, Remzi, Feza, Wright, Jason D., Friedman, Alexander M., Shaukat, Aasma, Wen, Timothy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1167
container_issue 7
container_start_page 1157
container_title Alimentary pharmacology & therapeutics
container_volume 56
creator Faye, Adam S.
Lee, Kate E.
Dodson, John
Chodosh, Joshua
Hudesman, David
Remzi, Feza
Wright, Jason D.
Friedman, Alexander M.
Shaukat, Aasma
Wen, Timothy
description Summary Background Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited. Aims To assess national trends in VTE‐associated hospitalisations among patients with IBD as well as risk factors for, and mortality associated with, these events Methods Using the U.S. Nationwide Inpatient Sample from 2000–2018, temporal trends in VTE were assessed using the National Cancer Institute's Joinpoint Regression Program with estimates presented as the average annual percent change (AAPC) with 95% confidence intervals (CIs). Results Between 2000 and 2018, there were 4,859,728 hospitalisations among patients with IBD, with 128,236 (2.6%) having a VTE, and 6352 associated deaths. The rate of VTE among hospitalised patients with IBD increased from 192 to 295 cases per 10,000 hospitalisations (AAPC 2.4%, 95%CI 1.4%, 3.4%, p 
doi_str_mv 10.1111/apt.17162
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2694962441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2711077265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3532-13ddcf430a339c65264fc1eee4237051964a4ff1af9bd4c3b5c99cd20d0ae05b3</originalsourceid><addsrcrecordid>eNp10U9rFDEYBvAgFrtWD34BCXjRw7T5N5mOt1LUFgr1UM_DO8kbN2UmGZNslz30u5u6bQ9CAyEQfjzkzUPIB86OeV0nsJRj3nEtXpEVl7ptBJP6NVkxoftGnHJ5SN7mfMsY0x0Tb8ihbE-7Xki-IveXwSSE7MNvmqBgptHROwxxk2lZpziPEeuefJ4pzLGqdcyLL1Bv0NIFisdQMt36sqY-uAnmGUpMOzrGLU7UVgYZv1KgodoYtt4ihQDTLvv8jhw4mDK-fzyPyK_v327OL5qr6x-X52dXjZGtFA2X1hqnJAMpe6NboZUzHBGVkB1rea8VKOc4uH60ysixNX1vrGCWAbJ2lEfk8z53SfHPBnMZZp8NThMErJMO9Z9Ur4VSvNJP_9HbuEn1vVV1nLOuE7qt6stemRRzTuiGJfkZ0m7gbHjoZKidDP86qfbjY-JmnNE-y6cSKjjZg62fcPdy0nD282Yf-Renw5ht</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2711077265</pqid></control><display><type>article</type><title>Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Faye, Adam S. ; Lee, Kate E. ; Dodson, John ; Chodosh, Joshua ; Hudesman, David ; Remzi, Feza ; Wright, Jason D. ; Friedman, Alexander M. ; Shaukat, Aasma ; Wen, Timothy</creator><creatorcontrib>Faye, Adam S. ; Lee, Kate E. ; Dodson, John ; Chodosh, Joshua ; Hudesman, David ; Remzi, Feza ; Wright, Jason D. ; Friedman, Alexander M. ; Shaukat, Aasma ; Wen, Timothy</creatorcontrib><description>Summary Background Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited. Aims To assess national trends in VTE‐associated hospitalisations among patients with IBD as well as risk factors for, and mortality associated with, these events Methods Using the U.S. Nationwide Inpatient Sample from 2000–2018, temporal trends in VTE were assessed using the National Cancer Institute's Joinpoint Regression Program with estimates presented as the average annual percent change (AAPC) with 95% confidence intervals (CIs). Results Between 2000 and 2018, there were 4,859,728 hospitalisations among patients with IBD, with 128,236 (2.6%) having a VTE, and 6352 associated deaths. The rate of VTE among hospitalised patients with IBD increased from 192 to 295 cases per 10,000 hospitalisations (AAPC 2.4%, 95%CI 1.4%, 3.4%, p &lt; 0.001), and remained significant when stratified by ulcerative colitis (UC) and Crohn's disease as well as by deep vein thrombosis and pulmonary embolism. On multivariable analysis, increasing age, male sex, UC (aOR: 1.30, 95%CI 1.26, 1.33), identifying as non‐Hispanic Black, and chronic corticosteroid use (aOR: 1.22, 95%CI 1.16, 1.29) were associated with an increased risk of a VTE‐associated hospitalisation. Conclusion Rates of VTE‐associated hospitalisations are increasing among patients with IBD. Continued efforts need to be placed on education and risk reduction. Increasing Rates of Venous Thromboembolism Among Hospitalized Patients with Inflammatory Bowel Disease.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.17162</identifier><identifier>PMID: 35879231</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Chronic Disease ; Colitis, Ulcerative - complications ; Colitis, Ulcerative - epidemiology ; Crohn Disease - complications ; Crohn Disease - epidemiology ; Crohn's disease ; deep vein thrombosis ; Embolism ; Hospitalization ; Humans ; Inflammatory bowel disease ; Inflammatory bowel diseases ; Inflammatory Bowel Diseases - complications ; Inflammatory Bowel Diseases - epidemiology ; Intestine ; Male ; Morbidity ; Mortality ; prophylaxis ; Pulmonary Embolism ; Pulmonary embolisms ; Risk Factors ; socioeconomic ; Thromboembolism ; Thrombosis ; Trends ; Ulcerative colitis ; Venous Thromboembolism - epidemiology ; Venous Thromboembolism - etiology</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2022-10, Vol.56 (7), p.1157-1167</ispartof><rights>2022 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2022 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3532-13ddcf430a339c65264fc1eee4237051964a4ff1af9bd4c3b5c99cd20d0ae05b3</citedby><cites>FETCH-LOGICAL-c3532-13ddcf430a339c65264fc1eee4237051964a4ff1af9bd4c3b5c99cd20d0ae05b3</cites><orcidid>0000-0002-0171-7121</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.17162$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.17162$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35879231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Faye, Adam S.</creatorcontrib><creatorcontrib>Lee, Kate E.</creatorcontrib><creatorcontrib>Dodson, John</creatorcontrib><creatorcontrib>Chodosh, Joshua</creatorcontrib><creatorcontrib>Hudesman, David</creatorcontrib><creatorcontrib>Remzi, Feza</creatorcontrib><creatorcontrib>Wright, Jason D.</creatorcontrib><creatorcontrib>Friedman, Alexander M.</creatorcontrib><creatorcontrib>Shaukat, Aasma</creatorcontrib><creatorcontrib>Wen, Timothy</creatorcontrib><title>Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Summary Background Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited. Aims To assess national trends in VTE‐associated hospitalisations among patients with IBD as well as risk factors for, and mortality associated with, these events Methods Using the U.S. Nationwide Inpatient Sample from 2000–2018, temporal trends in VTE were assessed using the National Cancer Institute's Joinpoint Regression Program with estimates presented as the average annual percent change (AAPC) with 95% confidence intervals (CIs). Results Between 2000 and 2018, there were 4,859,728 hospitalisations among patients with IBD, with 128,236 (2.6%) having a VTE, and 6352 associated deaths. The rate of VTE among hospitalised patients with IBD increased from 192 to 295 cases per 10,000 hospitalisations (AAPC 2.4%, 95%CI 1.4%, 3.4%, p &lt; 0.001), and remained significant when stratified by ulcerative colitis (UC) and Crohn's disease as well as by deep vein thrombosis and pulmonary embolism. On multivariable analysis, increasing age, male sex, UC (aOR: 1.30, 95%CI 1.26, 1.33), identifying as non‐Hispanic Black, and chronic corticosteroid use (aOR: 1.22, 95%CI 1.16, 1.29) were associated with an increased risk of a VTE‐associated hospitalisation. Conclusion Rates of VTE‐associated hospitalisations are increasing among patients with IBD. Continued efforts need to be placed on education and risk reduction. Increasing Rates of Venous Thromboembolism Among Hospitalized Patients with Inflammatory Bowel Disease.</description><subject>Chronic Disease</subject><subject>Colitis, Ulcerative - complications</subject><subject>Colitis, Ulcerative - epidemiology</subject><subject>Crohn Disease - complications</subject><subject>Crohn Disease - epidemiology</subject><subject>Crohn's disease</subject><subject>deep vein thrombosis</subject><subject>Embolism</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Inflammatory bowel disease</subject><subject>Inflammatory bowel diseases</subject><subject>Inflammatory Bowel Diseases - complications</subject><subject>Inflammatory Bowel Diseases - epidemiology</subject><subject>Intestine</subject><subject>Male</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>prophylaxis</subject><subject>Pulmonary Embolism</subject><subject>Pulmonary embolisms</subject><subject>Risk Factors</subject><subject>socioeconomic</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><subject>Trends</subject><subject>Ulcerative colitis</subject><subject>Venous Thromboembolism - epidemiology</subject><subject>Venous Thromboembolism - etiology</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10U9rFDEYBvAgFrtWD34BCXjRw7T5N5mOt1LUFgr1UM_DO8kbN2UmGZNslz30u5u6bQ9CAyEQfjzkzUPIB86OeV0nsJRj3nEtXpEVl7ptBJP6NVkxoftGnHJ5SN7mfMsY0x0Tb8ihbE-7Xki-IveXwSSE7MNvmqBgptHROwxxk2lZpziPEeuefJ4pzLGqdcyLL1Bv0NIFisdQMt36sqY-uAnmGUpMOzrGLU7UVgYZv1KgodoYtt4ihQDTLvv8jhw4mDK-fzyPyK_v327OL5qr6x-X52dXjZGtFA2X1hqnJAMpe6NboZUzHBGVkB1rea8VKOc4uH60ysixNX1vrGCWAbJ2lEfk8z53SfHPBnMZZp8NThMErJMO9Z9Ur4VSvNJP_9HbuEn1vVV1nLOuE7qt6stemRRzTuiGJfkZ0m7gbHjoZKidDP86qfbjY-JmnNE-y6cSKjjZg62fcPdy0nD282Yf-Renw5ht</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Faye, Adam S.</creator><creator>Lee, Kate E.</creator><creator>Dodson, John</creator><creator>Chodosh, Joshua</creator><creator>Hudesman, David</creator><creator>Remzi, Feza</creator><creator>Wright, Jason D.</creator><creator>Friedman, Alexander M.</creator><creator>Shaukat, Aasma</creator><creator>Wen, Timothy</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0171-7121</orcidid></search><sort><creationdate>202210</creationdate><title>Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis</title><author>Faye, Adam S. ; Lee, Kate E. ; Dodson, John ; Chodosh, Joshua ; Hudesman, David ; Remzi, Feza ; Wright, Jason D. ; Friedman, Alexander M. ; Shaukat, Aasma ; Wen, Timothy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3532-13ddcf430a339c65264fc1eee4237051964a4ff1af9bd4c3b5c99cd20d0ae05b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Chronic Disease</topic><topic>Colitis, Ulcerative - complications</topic><topic>Colitis, Ulcerative - epidemiology</topic><topic>Crohn Disease - complications</topic><topic>Crohn Disease - epidemiology</topic><topic>Crohn's disease</topic><topic>deep vein thrombosis</topic><topic>Embolism</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Inflammatory bowel disease</topic><topic>Inflammatory bowel diseases</topic><topic>Inflammatory Bowel Diseases - complications</topic><topic>Inflammatory Bowel Diseases - epidemiology</topic><topic>Intestine</topic><topic>Male</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>prophylaxis</topic><topic>Pulmonary Embolism</topic><topic>Pulmonary embolisms</topic><topic>Risk Factors</topic><topic>socioeconomic</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><topic>Trends</topic><topic>Ulcerative colitis</topic><topic>Venous Thromboembolism - epidemiology</topic><topic>Venous Thromboembolism - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Faye, Adam S.</creatorcontrib><creatorcontrib>Lee, Kate E.</creatorcontrib><creatorcontrib>Dodson, John</creatorcontrib><creatorcontrib>Chodosh, Joshua</creatorcontrib><creatorcontrib>Hudesman, David</creatorcontrib><creatorcontrib>Remzi, Feza</creatorcontrib><creatorcontrib>Wright, Jason D.</creatorcontrib><creatorcontrib>Friedman, Alexander M.</creatorcontrib><creatorcontrib>Shaukat, Aasma</creatorcontrib><creatorcontrib>Wen, Timothy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Faye, Adam S.</au><au>Lee, Kate E.</au><au>Dodson, John</au><au>Chodosh, Joshua</au><au>Hudesman, David</au><au>Remzi, Feza</au><au>Wright, Jason D.</au><au>Friedman, Alexander M.</au><au>Shaukat, Aasma</au><au>Wen, Timothy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2022-10</date><risdate>2022</risdate><volume>56</volume><issue>7</issue><spage>1157</spage><epage>1167</epage><pages>1157-1167</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Summary Background Venous thromboembolism (VTE) is a significant cause of morbidity and mortality among patients with inflammatory bowel disease (IBD). However, data on national trends remain limited. Aims To assess national trends in VTE‐associated hospitalisations among patients with IBD as well as risk factors for, and mortality associated with, these events Methods Using the U.S. Nationwide Inpatient Sample from 2000–2018, temporal trends in VTE were assessed using the National Cancer Institute's Joinpoint Regression Program with estimates presented as the average annual percent change (AAPC) with 95% confidence intervals (CIs). Results Between 2000 and 2018, there were 4,859,728 hospitalisations among patients with IBD, with 128,236 (2.6%) having a VTE, and 6352 associated deaths. The rate of VTE among hospitalised patients with IBD increased from 192 to 295 cases per 10,000 hospitalisations (AAPC 2.4%, 95%CI 1.4%, 3.4%, p &lt; 0.001), and remained significant when stratified by ulcerative colitis (UC) and Crohn's disease as well as by deep vein thrombosis and pulmonary embolism. On multivariable analysis, increasing age, male sex, UC (aOR: 1.30, 95%CI 1.26, 1.33), identifying as non‐Hispanic Black, and chronic corticosteroid use (aOR: 1.22, 95%CI 1.16, 1.29) were associated with an increased risk of a VTE‐associated hospitalisation. Conclusion Rates of VTE‐associated hospitalisations are increasing among patients with IBD. Continued efforts need to be placed on education and risk reduction. Increasing Rates of Venous Thromboembolism Among Hospitalized Patients with Inflammatory Bowel Disease.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35879231</pmid><doi>10.1111/apt.17162</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-0171-7121</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2022-10, Vol.56 (7), p.1157-1167
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_2694962441
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals
subjects Chronic Disease
Colitis, Ulcerative - complications
Colitis, Ulcerative - epidemiology
Crohn Disease - complications
Crohn Disease - epidemiology
Crohn's disease
deep vein thrombosis
Embolism
Hospitalization
Humans
Inflammatory bowel disease
Inflammatory bowel diseases
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - epidemiology
Intestine
Male
Morbidity
Mortality
prophylaxis
Pulmonary Embolism
Pulmonary embolisms
Risk Factors
socioeconomic
Thromboembolism
Thrombosis
Trends
Ulcerative colitis
Venous Thromboembolism - epidemiology
Venous Thromboembolism - etiology
title Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T10%3A47%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increasing%20rates%20of%20venous%20thromboembolism%20among%20hospitalised%20patients%20with%20inflammatory%20bowel%20disease:%20a%20nationwide%20analysis&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Faye,%20Adam%20S.&rft.date=2022-10&rft.volume=56&rft.issue=7&rft.spage=1157&rft.epage=1167&rft.pages=1157-1167&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.17162&rft_dat=%3Cproquest_cross%3E2711077265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2711077265&rft_id=info:pmid/35879231&rfr_iscdi=true